T he recruitment of leukocytes into sites of inflammation and lymphoid tissues involves leukocyte interactions with vascular endothelium under shear flow. These interactions are initiated by weak reversible recognition of endothelial ligands followed by firm adhesion mediated by members of the integrin family and their respective Ig family ligands (1) . ␤ 2 Integrins are the major cell-cell adhesion receptors on leukocytes, and they participate in versatile adhesive processes of these cells within the vasculature (1) . These processes include the arrest of immune cells on vessel walls at sites of inflammation or lymphoid tissues, transendothelial migration, and final localization at sites of Ag presentation (1, 2) . LFA-1 (␣ L ␤ 2 ) is the major ␤ 2 integrin on lymphocytes that mediates binding to ICAMs, Ig family integrin ligands expressed on venular endothelia and on APC, effector immune cells, and activated platelets (3) (4) (5) (6) . ICAM-1 (CD54) is the major LFA-1 ligand; it is ubiquitously found on most leukocytes and endothelial cells, where it is up-regulated during inflammation. ICAM-1 is a bent rod and contains five Ig-like domains oriented head to tail (7) . Domain 1 of ICAM-1, the most membrane-distal, contains the primary site of contact for LFA-1 (8) .
LFA-1 has been postulated to require activation to support firm adhesion to its different ICAM ligands (9, 10) . High-avidity LFA-1 binding to endothelial ICAM-1 is triggered on circulating leukocytes after they have established weak rolling adhesions on the vessel wall through selectins, CD44, or VAP-1 (1, 11) . However, several integrins like ␣ 4 ␤ 1 and ␣ 4 ␤ 7 occur in constitutively adhesive states on circulating leukocytes and can also support rolling adhesions on their respective endothelial ligands (12) (13) (14) (15) . The inability of ␤ 2 integrins to participate in similar rolling interactions between leukocytes and vascular endothelium has been attributed to the critical dependence of their adhesiveness on prior activation of chemoattractant receptors coupled to heterotrimeric G-proteins on circulating leukocytes (16 -18) .
Controlled flow assays performed in laminar flow chambers have been useful in the characterization of transient and weak adhesive interactions between cells and surface-immobilized ligands or Abs (19) . Using these assays to generate low-range detachment forces, relatively weak adhesions between integrins on resting cells and immobilized ligands can be detected and quantified (20 -22) . Testing LFA-1 adhesiveness to ICAM-1 in the human leukemia cell Jurkat as a prototypic T cell model, we show in this paper that LFA-1 can spontaneously form weak but specific adhesion to immobilized ICAM-1. Subsets of PBL were also found to develop LFA-1 adhesions of considerable strength upon short contact with ICAM-1-coated surfaces. Under identical conditions, stable adhesion to ICAM-1 of K562 cells transfected with LFA-1 was not observed. Nevertheless, when exposed to physiological shear stresses, LFA-1-expressing K562 cells established persistent rolling on ICAM-1. These results extend previous findings, which showed that the isolated I-domain of LFA-1 can engage in rolling interactions with high-density ICAM-1 and ICAM-3 (23) . This is the first indication that the intact LFA-1 integrin, when placed in a permissive cellular environment, can support rolling adhesions on physiological densities of ICAM-1 under physiological shear flow. Furthermore, this study provides evidence that cell-type-dependent differences in LFA-1 avidity states, but not intrinsic affinity properties, control LFA-1 ability to support rolling adhesions on ICAM-1 under physiological shear flow.
Materials and Methods

Abs and reagents
All mAbs were used as purified IgGs. The function-blocking anti-LFA-1 mAb NKI-L15 and the nonblocking mAbs SPV-L7 and NKI-L16, directed against the ␣ subunit of LFA-1, were produced as previously described (24) . TS1.22, a function-blocking anti-LFA-1 mAb directed against the I-domain of the integrin ␣ subunit (25) , and mAb R 6.5, an anti-ICAM-1 mAb directed against the LFA-1 recognition site on the first Ig-like domain of ICAM-1 (26) , were the generous gift of Dr. T. Springer, (Center for Blood Research, Harvard Medical School, Boston, MA). TS2.4, a nonblocking anti-LFA-1 mAb (25), was kindly provided by Dr. E. Martz. HP 1/2, a very late Ag-4 (VLA-4) 3 -specific mAb (27) , was a kind gift of Dr. R. Lobb (Biogen, Cambridge, MA). The anti-␤ 2 mAb KIM185 was used to activate LFA-1 (28 
Cells
K562 cells stably expressing LFA-1 (30) were maintained in RPMI 1640/ Iscove's medium (3:1 v/v) supplemented with 5% heat-inactivated FCS (Biological Industries, Beit Hahemek, Israel), 1% penicillin/streptomycin (Bio Lab, Jerusalem, Israel), and 2 mg/ml G418 (Calbiochem) to selectively maintain the transfected population. The ␤ 2 deletion mutant ␣ L ␤ 2 / ⌬724 generated by truncation of the ␤ 2 cytoplasmic tail at amino acid position 724 close to the transmembrane region (30) was stably expressed in K562 cells maintained as above. The Jurkat T lymphoblastoid cell line was maintained in RPMI 1640 supplemented with 10% heat-inactivated FCS (Sigma), 2 mM L-glutamine, and 1% antibiotics. Human peripheral blood lymphocytes (obtained from healthy donors) were isolated from citrate-anticoagulated whole blood by dextran sedimentation and density separation over Ficoll-Hypaque (20) . The mononuclear cells thus obtained were washed and further purified on nylon wool and by further panning on serum-coated dishes. The resulting purified PBL were more than 90% CD3-positive T lymphocytes. PBL were maintained in RPMI 1640 supplemented with 10% heat-inactivated FCS for 15-18 h after isolation and purification until use.
Flow cytometry
A total of 10 6 cells were incubated for 1 h on ice in 20 g/ml of the ␣LFA-1 mAb TS1.22 and control mAb 4B9 in a solution of PBS with 1% BSA and 0.05% sodium azide (FACS buffer). Cells were washed three times in FACS buffer and incubated for 15 min on ice with 5 g/ml FITCconjugated goat anti-mouse IgG (Zymed) in FACS buffer. Cells were washed three times and analyzed by FACSort flow cytometer (Becton Dickinson).
ICAM-1-Fc binding to cells was determined by immunofluorescence by incubating 50,000 cells in TSA binding medium (20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM Ca 2ϩ , 2 mM Mg 2ϩ , and 5 mg/ml BSA) with or without LFA-1 blocking mAb (20 g/ml) for 10 min at room temperature (RT) in a 96-well V-bottom plate. 
Fluorescent beads adhesion assay
Cells were resuspended in TSA binding medium (5 ϫ 10 6 cells/ml). A total of 50,000 cells were preincubated with or without LFA-1-blocking mAb (20 g/ml) for 10 min at RT in a 96-well V-bottom plate, alone or in the presence of 100 ng/ml PMA. Ligand-coated TransFluoSpheres (1 m; Molecular Probes, Eugene, OR) were incubated with different experimental groups (at a ratio of 20 beads/cell) for 30 min at 37°C. The cells were washed with TSA, and LFA-1-mediated bead adhesion was measured by flow cytometry using FACScan as previously described (31) . Values are depicted as integrin-specific adhesion, i.e., (percentage of cells binding to beads in the absence of the LFA-1 blocking mAb (NKI-L15)) Ϫ (percentage of cells binding to beads in the presence of the LFA-1 blocking mAb).
Confocal microscopy
Cells were fixed with 0.5% paraformaldehyde and stained with TS2/4 mAb (10 g/ml) for 30 min at 37°C before incubation with FITC-labeled goat F(abЈ) 2 anti-mouse IgG mAb for 30 min at RT. Cells were attached to polyl-lysine-coated glass slides, and cell surface distribution of integrins was determined by confocal laser scanning microscopy (CLSM) at 488 nm with a krypton/argon laser (Bio-Rad 1000; Bio-Rad, Hercules, CA).
Laminar flow assays
Preparation of adhesive substrates. Recombinant sICAM-1 was dissolved in coating medium (PBS buffered with 20 mM bicarbonate (pH 8.5)) and directly coated to a polystyrene plate (60 ϫ 15 mm petri dish; Becton Dickinson, Lincoln Park, NJ) for 2 h at 37°C. The plate was washed three times with PBS and blocked with HSA (20 mg/ml in PBS) overnight at 4°C. ICAM-1-Fc-coated substrates were prepared as previously described (32) . Protein A (20 g/ml in coating medium) was spotted onto a polystyrene plate, and the substrate was washed and blocked with HSA (20 mg/ml in PBS). The protein A-coated substrate was overlaid overnight at 4°C with 0.5-10 g/ml of ICAM-1-Fc in PBS supplemented with HSA. The adsorbed chimeric ICAM-1 was shown to bind the protein A-coated substrate exclusively through its Fc region, as verified by the ability of excess human IgG to compete off all ICAM-1-Fc adsorption onto the substrate. LFA-1-specific mAbs were coated (5 g/ml in PBS/HSA) on surfaces precoated with protein A and overlaid with IgG-Fc-specific rabbit anti-mouse (5 g/ml in PBS/HSA). The density of functional sICAM-1 coated on the substrate was determined by saturation binding of 125 I-labeled anti-ICAM-1 mAb, R 6.5. The site density of ICAM-1-Fc adsorbed to the protein A substrates was determined from overlay experiments with 125 I-labeled ICAM-1-Fc. Labeled fusion protein or ICAM-1 mAb were prepared by the chloramine T method (33), using a ratio of 50 g protein to 0.5 mCi of carrier-free [
125 I]Na (Amersham, Buckinghamshire, U.K.).
Determination of cell adhesion to ICAM-1 in stasis and under flow. A polystyrene coated with an adhesive ligand was assembled in a parallel-plate laminar flow chamber (260-m gap) and mounted on the stage of an inverted phase contrast microscope (Diaphot 300; Nikon, Tokyo, Japan) as previously described (13, 34) . Cell images were videotaped with a long-integration LIS-700 CCD video camera (Applitech, Holon, Israel) and a Panasonic AG-6730 SVHS video recorder (Panasonic, Osaka, Japan). Cultured cells were washed twice with cation-free H/H medium (HBSS containing BSA (2 mg/ml) and 10 mM HEPES (pH 7.4)) containing 5 mM EDTA, resuspended in H/H medium, and kept at RT until use. Cells were suspended at RT in binding medium (H/H supplemented with 1 mM each of Ca 2ϩ and Mg 2ϩ ; also referred to as physiological binding medium). Alternatively, cells were suspended in H/H supplemented with 2 mM Mg 2ϩ , alone or with 0.5 mM EGTA (Mg 2ϩ /EGTA). Suspended cells (10 6 cells/ml) were perfused through the flow chamber and allowed to settle on the plate for different periods in the absence of flow or were perfused through the chamber for 1 min at a constant low shear flow (0.25 dyn/cm 2 , unless otherwise indicated) before being subjected to an incremental increase in shear stress. Shear flow was generated and automatically controlled with an automated syringe pump (Harvard Apparatus, Natick, MA) attached to the outlet side of the flow chamber. The wall shear stress was increased step-wise every 5 s (by a programmed set of flow rates) until it reached 10 dyn/cm 2 . At the end of each 5-s interval at a particular shear stress, the number of cells that remained bound (stationary or rolling; see below) was determined relative to the number of cells originally settled in stasis or relative to the number of cells that had accumulated at low shear flow on the ICAM-1-coated field. Cellular interactions were determined on two representative fields of view (each typically 0.34 mm 2 of area). For Ab inhibition studies, cells (10 7 /ml) were preincubated (5 min; 4°C) in H/H medium with LFA-1 blocking mAb (20 g/ml). The cells were diluted 1:10 into binding medium without washing out the Abs, and the suspension was perfused into the flow chamber. To selectively block high-affinity LFA-1 on compared cells, cells were suspended in binding medium containing soluble ICAM-1-Fc (0.5-1 g/ml) or control VCAM-1-Fc for 5 min at 24°C and then perfused through the flow chamber without diluting out the soluble ligands. For metabolic energy inhibition experiments, cells (2 ϫ 10 7 /ml) were treated (10 min; 22°C) with 0.1% sodium azide (Sigma) and 50 mM 2-deoxyglucose (2-DOG; Sigma) in H/H medium and then diluted (1:5) with binding medium and immediately perfused into the flow chamber.
Determination of rolling fractions and rolling velocities. Cells
interacting with ICAM-1 were defined as arrested if they adhered to the substrate and remained motionless throughout the shear-flow interval examined. Cellular motions were defined as rolling if they persisted for at least 4 s at a mean velocity Ͼ2 m/s that was reduced at least 20-fold compared with a freely flowing cell at a given shear stress. Some cells that arrested after tethering to high-density ICAM-1 under low shear flow began rolling when subjected to elevated shear stresses. The rolling fraction at a given shear stress was defined as: [(no. of rolling cells) ϫ 100]/(no. of rolling cells ϩ no. of stationary cells). The mean rolling velocities of cell populations at a given shear stress were determined by measuring the displacements of 15-20 cells over 5-s shear intervals.
Image analysis. Quantitative analysis of cell displacements was per-
formed with the WSCAN-Array-3 imaging software (Galai, MigdalHa'emek, Israel). Video frame images were digitized using a Matrox Pulsar frame grabber (Matrox Graphics, Dorval, Quebec, Canada) and processed by software running on an Atlas Pentium MMX-200 work station. The program output provided the coordinates of the center point of each cell with time, and analysis was performed with a dedicated software run under Matlab 5.2 (developed in collaboration with the lab of Prof. David Malah, Signal and Image Processing Lab, Technion, Haifa, Israel). Selected video images were also digitized on a G3 Macintosh using a Media100 frame grabber, and cellular motions were tracked using the DIAS imaging software (Solltech, Oakdale, IA).
Results
LFA-1 expressed in K562 cells supports rolling adhesions on ICAM-1 under physiological shear flow
To assess the magnitude of adhesiveness spontaneously developed by LFA-1 during brief cell contact with ICAM-1, we used a controlled flow assay to study weak LFA-1-dependent adhesion of various cell types to ICAM-1 substrates. LFA-1-mediated adhesion of the T cell leukemia line Jurkat was compared with that of K562 cells transfected with LFA-1 cDNA (K562-LFA-1 cells). The level of LFA-1 expressed on both cell types was comparable, although it was somewhat more heterogeneous in the K562 transfectants ( Fig. 1 ). Substrates were coated with a recombinant human ICAM-1-Fc fusion protein by overlaying the protein on plastic precoated with protein A. Unstimulated Jurkat and K562-LFA-1 cells failed to develop firm adherence to immobilized ICAM-1 in conventional tip plate adhesion assays (data not shown). Nevertheless, when allowed to briefly settle on ICAM-1-coated substrates assembled in a flow chamber, significant fractions of both cell types developed considerable LFA-1-specific adhesion to ICAM-1 even without stimulation ( Fig. 2A) . Adhesion of both cell types was entirely LFA-1-dependent because it was blocked in the presence of the LFA-1-blocking mAb TS1.22 or by integrin inhibition in the presence of EDTA ( Fig. 2A and data not  shown) . VLA-4-expressing K562 cells failed to adhere to identical ICAM-1 substrates (Fig. 2A) . Replacement of Ca 2ϩ by Mg 2ϩ , which induces a high-affinity state on LFA-1 without dependence on intracellular signaling events, increased LFA-1 adhesiveness to ICAM-1 in both cell types to a comparable degree (Fig. 2A) . The fraction of Jurkat cells that spontaneously adhered to ICAM-1 was markedly higher than that of K562-LFA-1 cells, both in medium containing Ca 2ϩ and Mg 2ϩ and in medium containing Mg 2ϩ alone. Strikingly, when K562-LFA-1 cells adhered to ICAM-1 were subjected to a physiological shear stress higher than 1 dyn/cm 2 , the majority of cells started to roll on the ICAM-1 substrate in a persistent manner, reminiscent of selectin-mediated rolling assayed in similar flow assays (Fig. 2, B and C) . Rolling required a threshold of ICAM-1 density because it diminished on substrates coated at densities below 80 sites/m 2 (data not shown). The median strength of LFA-1-transfected K562 cell adhesions i.e., the shear stress causing the detachment of half of originally adherent cells, also varied with ICAM-1 density. (Fig. 2B) . Recently, ICAM-1 dimerization has been shown to strengthen LFA-1-mediated adhesions (35) . ICAM-1 dimerization within the ICAM-1-Fc chimera did not appear obligatory for efficient LFA-1-mediated rolling because LFA-1 adhesiveness to monovalent ICAM-1, sI-CAM-1, directly immobilized on the substrate was comparable to LFA-1 adhesiveness to the dimeric ICAM-1-Fc when both were present at high site densities (Fig. 3) . Notably, the ability of K562-LFA-1 cells to roll on ICAM-1 did not depend on a prior contact with immobilized ICAM-1. Cells tethered at shear flow to highdensity ICAM-1 substrates (Fig. 3) continued to efficiently roll on the substrates, similarly to cells statically adhered and then subjected to shear flow (Fig. 2) .
Rolling velocity through LFA-1 is modulated by cations and is only moderately increased by elevated shear stresses
Agonists of VLA-4 affinity to VCAM-1 such as Mn 2ϩ or Mg 2ϩ have been shown to slow integrin-mediated rolling (13) . Therefore, we asked how LFA-1 rolling on ICAM-1 is regulated by divalent cations. Although rolling adhesions of K562-LFA-1 cells increased in the presence of Mg 2ϩ alone (Fig. 2, A and B) , the velocities of cells rolling on ICAM-1 in the presence of this cation alone were not significantly different from those measured in physiological concentrations of Ca 2ϩ and Mg 2ϩ (Fig. 4A) . LFA-1 binding to ICAM-1 in the presence of Mg 2ϩ can be increased by chelation of residual Ca 2ϩ in the presence of EGTA because Ca 2ϩ exclusion stabilizes LFA-1 in a conformation with high affinity for ICAM-1 (36) . Indeed, in the presence of Mg 2ϩ /EGTA, the fraction of adherent K562-LFA-1 cells rolling on ICAM-1 was sharply reduced (Fig. 4B, inset) , and the cells that could still roll on ICAM-1 did so at 5-to 7-fold slower velocities than in the presence of Mg 2ϩ alone (Fig. 4B) . A characteristic of rolling adhesions mediated by selectins and ␣ 4 integrins is that rolling velocity increases with increasing shear forces (13, 34) . A remarkable feature of LFA-1-mediated rolling demonstrated by our experiments was the invariance of rolling velocity with elevated shear stress (Fig. 4, A and B) . To rule out the possibility that cells with higher resistance to detachment from ICAM-1, and therefore higher avidity of LFA-1 and slower rolling dynamics, were enriched within the population of cells remaining rolling on ICAM-1 at elevated shear stresses, single cells were analyzed for their displacement with time at continuously incremented shear stress. Surprisingly, rolling velocities of individual K562-LFA-1 remained constant (Fig. 4C, open symbols) or increased only moderately with elevated shear stress (Fig. 4C, f) . This peculiar dynamic behavior was seen only in cell subsets that exhibited higher resistance to detachment by elevated shear stresses. Thus, highly adhesive LFA-1-expressing K562 cells could overcome the destabilizing effects of elevated shear stress, which lead to faster rolling and enhanced detachment in the more weakly adhered K562-LFA-1 cells. 2 ) in physiological medium at incremented shear stresses. Cells were allowed to accumulate for 1 min on the ICAM-1 substrate at 0.25 dyn/cm 2 and then were subjected to incremented shear stresses as described in Fig. 2 . The wall shear stress was increased at the indicated time points of the observation period. Cell positions were determined at 0. 
LFA-1 tail-deletion mutant expressed in K562 cells exhibits high avidity to ICAM-1 concomitant with loss of rolling
To study how increased LFA-1 avidity to ICAM-1 can modulate interactions between this integrin ligand pair under shear flow, we compared the dynamic properties of wild-type (wt) LFA-1 and an LFA-1 cytoplasmic tail deletion mutant. The ␤ 2 subunit tail deletion mutant ␣ L ␤ 2 /⌬724 exhibits constitutive high avidity to ICAM-1 and high expression of the activation epitope M24 concomitant with ligand-independent clustering (30, 37), yet it binds soluble ICAM-1-Fc with affinity similar to that of wt LFA-1 (37) . K562 cells expressing the deletion mutant at levels identical to those of K562-LFA-1 cells (not shown) accumulated on both high-and low-density ICAM-1 at strikingly higher levels than did K562-LFA-1 under shear flow (Fig. 5A) . The ␤ deletion mutantexpressing cells immediately arrested upon tethering to ICAM-1 and remained arrested on the ligand without ability to roll even when exposed to elevated shear stresses that caused their detachment from ICAM-1 (Fig. 5A) . The resistance to detachment from ICAM-1 of LFA-1 mutant-expressing cells was markedly higher than that of K562-LFA-1 cells on both bivalent (high-density) or monovalent (low-density) ICAM-1 (Fig. 5) . No rolling was supported by the mutant LFA-1 on ICAM-1 at any ligand concentration or shear stress tested, in contrast to highly efficient rolling mediated by wt LFA-1 (Fig. 5A ). These findings are consistent with the notion that enhanced LFA-1 avidity to ICAM-1 results in immediate adhesion strengthening under shear flow at the expense of reversible rolling interactions. Thus, even in a cellular environment permissive for LFA-1-mediated rolling like that of K562 cells, interference with the cytoskeletal association of LFA-1 through tail deletion abrogates the ability of the integrin to support rolling adhesions under physiological flow.
Modulation of LFA-1 avidity in T cells does not produce rolling reactivity
Metabolic energy is essential for optimal integrin function (38) . Energy depletion of Jurkat cells by sodium azide and 2-deoxyglucose enhances VLA-4-mediated rolling on VCAM-1 at the expense of firm adhesion associated with reduction of integrin affinity to ligand (22) . Therefore, we asked whether a similar energy depletion treatment of resting T cells would enhance their LFA-1 rolling on ICAM-1. However, metabolic energy depletion of Jurkat cells and PBL by azide/2-deoxyglucose greatly decreased LFA-1 adhesion to ICAM-1 without promoting LFA-1 rolling (Fig. 6) . Phorbol esters like PMA are strong agonists of integrin adhesion in leukocytes (13, 39 -42) . PMA treatment enhances LFA-1 adhesiveness in T cells by augmenting integrin clustering rather than affinity to ligand (43, 44) . Therefore, we set out to determine whether PMA stimulation of T cell LFA-1 can render a fraction of LFA-1-expressing cells capable of rolling on ICAM-1 under shear flow. PMA stimulation of PBL increased the number of PBL that arrested on ICAM-1 under low flow by 3-fold, but did not render any subset of treated cells capable of rolling on ICAM-1 (Fig. 6B) .
LFA-1 avidity to ICAM-1 is lower in K562 cells than in T cells despite conserved affinity and constitutive clustering
The markedly stronger adhesion developed by T cell LFA-1, together with its inability to support rolling, suggests that LFA-1 avidity to ICAM-1 is higher in Jurkat T cells, as well as in PBL, than in K562 cells. Consistent with such a possibility, Jurkat cells could bind ICAM-1-coated beads better than K562 cells could in physiological medium in the absence of shear flow, even without cell stimulation (Fig. 7A) . Thus, markedly enhanced adhesiveness of Jurkat cell LFA-1 to surface-bound ICAM-1 could be observed even in shear-less conditions. Integrin-mediated adhesion to physiological ligands is dynamically regulated after ligand binding (29, 42, 44, 45) . LFA-1 adhesion strengthening is diffusion-limited and depends strongly on contact time with the immobilized ligand (43) . Consistent with the inherent defect in adhesion strengthening of wt LFA-1 on K562 cells, K562-LFA-1 transfectants could not develop firm adhesion to ICAM-1 even after prolonged contact with ligand (Fig. 7B) . When statically adhered to low-or high-density ICAM-1, only a small fraction of K562 cells developed detectable adhesion to ICAM-1 during 1 min of contact, and a 3-fold longer contact period with the ligand did not increase the fraction of K562-LFA-1 cells firmly adherent to ICAM-1 (Fig. 7B) . Notably, even though Jurkat cell adhesion developed over 1 min of contact was much higher than that of the K562-LFA-1 cells, it could be further enhanced by a 3-fold or 10-fold prolonged contact period with ICAM-1, in contrast to K562-LFA-1 adhesion (Fig. 7B and  data not shown) . These experiments collectively suggest that Jurkat LFA-1 and PBL develop firmer adhesion to surface-bound ICAM-1 than do K562-LFA-1 cells because of higher constitutive avidity of LFA-1 and higher contact-dependent adhesion strengthening of the integrin expressed in these T cells compared with K562 cells.
The reduced constitutive avidity of LFA-1 in the K562 cell system could reflect reduced intrinsic affinity to soluble ligand as well as lower constitutive clustering. ICAM-1-Fc bound saturably to K562-LFA-1, Jurkat cells, and subsets of PBL with comparable half-saturation concentrations (10 nM; data not shown), suggesting that the affinity of LFA-1 to ICAM-1 in solution is of the same order in both cell types. Direct binding measurements of soluble integrin ligands to their cell-surface receptors may discriminate against low-avidity LFA-1 subsets because of rapid dissociation of ligand from these subsets caused by removal of unbound ligand by cell washing. Therefore, we took an alternative approach to assess in situ the role of LFA-1 affinity in T cell and K562-LFA-1 cell adhesion to ICAM-1 under flow. Because high-affinity LFA-1 states are preferentially occupied by soluble ICAM-1 (36), we measured the extent of inhibition exerted by this soluble ligand on LFA-1-dependent cell adhesion to immobilized ICAM-1. ICAM-1-Fc inhibited in a dose-dependent manner both the accumulation on and resistance to detachment from ICAM-1 of PBL and of K562-LFA-1 cells interacting with ICAM-1 under shear flow (Fig.  8) . The similar ICAM-1-Fc dose dependence of LFA-1 adhesion seen with both cell types suggested that LFA-1 molecules with comparable levels of affinity contributed to LFA-1 adhesiveness in both PBL and K562-LFA-1 cells.
In light of the conserved affinity of LFA-1 toward ICAM-1 in both resting Jurkat cells and K562 cells, we next tested whether Jurkat cells exhibit higher constitutive clustering of LFA-1 relative to that on K562-LFA-1 cells. CLSM analysis of LFA-1 surface distribution revealed that the majority of LFA-1 in both cell types is not clustered under physiological conditions (Fig. 9) . Rather, LFA-1 was found either evenly diffused or in small patches on the entire cell surface of both cell types, but no major difference in the number or size of LFA-1 patches between the two cell types was detected (Fig. 9) . Consistent with the CLSM analysis, the levels of NKL16, a Ca 2ϩ -dependent LFA-1 clustering-associated epitope (46), were similar on both cell types; a comparable ratio of L16 staining to LFA-1 staining was observed in K562-LFA-1 (0.36 Ϯ 0.06) and in Jurkat cells (0.25 Ϯ 0.03). These results suggest that before ligand binding, LFA-1 on both Jurkat cells and K562 cells as well as on PBL (42) is largely unclustered. Thus, differences in constitutive preligand binding of LFA-1 in resting T cells and K562 cells cannot account for the firm adhesion to ICAM-1 rapidly developed by these cells but not by K562-LFA-1 cells under dynamic conditions of shear flow.
Discussion
This study demonstrates several novel concepts in LFA-1-mediated adhesion. First, LFA-1 exists in unstimulated PBL and in T cell lines in functionally adhesive states, which supports significant adhesion to immobilized ICAM-1 during short static contact with ligand. LFA-1 on subsets of T cells and K562 transfectants can develop different modes of adhesion to high-density ICAM-1 within fractions of a second, even without agonist stimulation. These types of LFA-1-mediated adhesion do not involve cell spreading triggered by ligand occupancy of LFA-1, which contributes to adhesion strengthening through diffusion-limited integrin clustering events (36) . Like early events of LFA-1-dependent adhesive cascades, these interactions are not discernible in standard adhesion assays, which apply stringent washing steps with high, uncontrolled detachment forces. Second, low-avidity LFA-1 states with similar affinity to that of soluble ICAM-1 can have strikingly different adhesive properties when expressed on different cellular backgrounds. In K562 cells, LFA-1 can establish weak rolling adhesions on ICAM-1 under physiological shear flow, the first direct demonstration that this integrin can associate rapidly and reversibly with ICAM-1 under flow conditions. In Jurkat T leukemia cells and in subsets of peripheral blood T lymphocytes, LFA-1 can spontaneously support high-avidity interactions with immobilized ICAM-1, leading to cellular arrest under shear flow. Third, the ability of LFA-1 to mediate cell rolling on ICAM-1 is associated with an impaired ability to undergo adhesion strengthening; increased adhesion strengthening by an LFA-1 tail mutant results in loss of rolling and its replacement by firm adhesion of K562 cells. Therefore, our findings indicate a reciprocal relationship between ability of LFA-1 to roll and to undergo adhesion strengthening under shear flow conditions.
To support reversible rolling adhesions, major rolling receptors like selectins need to rapidly and reversibly bind a small number of ligands at the adhesive contact zone (47) . To engage in rolling interactions with its endothelial ligand, LFA-1 might also need to be prevented from engaging in highly multivalent interactions with ICAM-1. We have shown that a ␤ 2 tail-truncated LFA-1 mutant with conserved affinity to ICAM-1 but impaired cytoskeletal constraints in the K562 cell system exhibited enhanced ability to undergo rapid adhesion strengthening on ICAM-1 under shear flow. These results suggest that the inability of wt LFA-1 to mediate rolling in Jurkat cells and PBL subsets may also result in reduced cytoskeletal constraints and hence increased adhesion strengthening of wt LFA-1 in T cells relative to those imposed on the integrin in K562 cells. Ligand-induced LFA-1 clustering in T cells requires the release of cytoskeletal restraints on LFA-1, which restricts its lateral clustering (42) (43) (44) . Notably, release of cytoskeletal constraints of LFA-1 and adhesion strengthening is facilitated upon T cell activation by PMA without alteration of LFA-1 affinity (36) . PMA fails to induce adhesion strengthening to ICAM-1 in K562 cells (37, 42) , which supports major reduced susceptibility of LFA-1 association with the actin cytoskeleton to PMA stimulation in these cells. Consistent with an inherent defect in LFA-1 release of cytoskeletal constraints in K562 cells, cytochalasin D treatment has been reported to induce LFA-1 clustering in resting PBL but not in K562 cells (30, 42) . Higher cytoskeletal restraints of LFA-1 in K562 cells and impaired adhesion strengthening may keep LFA-1:ICAM-1 interactions at low avidity and may allow reversible fast-breaking rolling interactions to form under constant shear flow. Thus, a cell-type-dependent restriction in LFA-1-mediated adhesion strengthening, rather than intrinsic integrin properties, appears to control the ability of LFA-1 to promote rolling adhesions of circulating leukocytes on its endothelial ligand. Enhanced constitutive clustering of LFA-1 before ligand binding has been shown to correlate with increased avidity to ICAM-1 in various cellular systems (42, 43) . However, the impaired ability of K562-LFA-1 to support high-avidity adherence was not because of impaired constitutive clustering of LFA-1 in K562 cells relative to Jurkat T cells or PBL (Fig. 9 and Refs. 30 and 42). Taken together, these observations suggest that the deficient adhesion strengthening properties of LFA-1 in K562 cells and the acquisition of a rolling phenotype by LFA-1 in these cells reflect a defect in postligand binding clustering, rather than a constitutive, i.e., preligand binding, LFA-1 clustering defect.
LFA-1-mediated rolling requires an intact I-domain, suggesting the critical contribution of this module to recognition of ICAM-1 under both static and dynamic conditions (48 (23) . This affinity is similar to the recently determined affinity between L-selectin and its endothelial ligand, glycosylation-dependent cell adhesion molecule-1 (50) . Nevertheless, the ability of LFA-1 to mediate rolling does not depend on its affinity to ligand because the affinity of LFA-1 to ICAM-1 in the T cell systems that failed to roll on ICAM-1 was not higher than LFA-1 affinity in the K562 cells that efficiently rolled on the LFA-1 ligand. ICAM-1-Fc bound saturably to K562-LFA-1 and Jurkat cells with comparable half-saturation concentrations (10 nM; data not shown), and comparable levels of high-affinity LFA-1 contributed to adhesion of both T cells and K562-LFA-1 cells to ICAM-1 because both cells exhibited similar susceptibility to inhibition by soluble ICAM-1. Therefore, our results suggest that affinity-independent mechanisms of integrin clustering control LFA-1 ability to undergo adhesion strengthening in T cells and also engage weak reversible rolling interactions on ICAM-1 in K562 cells. Cell adhesive bonds that support rolling adhesions have been suggested to share fast kinetics of formation and dissociation (47, 51) . Cellular environment may alter the kinetics of tether bond formation under flow, and faster kinetics of bond formation by LFA-1 can be favored by increased cell-surface availability of the integrin (52-54). ␤ 2 Integrins are generally excluded from microvilli in most leukocytes (55) . A recent study showed that about 30% of LFA-1 is located on microvilli in transfected K562 cells (55) . Our electron microscopy studies confirm that more than 20% of the cell-surface LFA-1 in K562 cells is localized to microvilli, whereas a diminished fraction of LFA-1 on Jurkat cells or PBL is distributed to these cellular projections (Y.V.K., unpublished observations). Nevertheless, exclusion of selectins from microvilli does not preclude their ability to support rolling (54) , suggesting that exclusion of LFA-1 from these surface extensions in T cells could not have accounted for the complete loss of rolling activity of LFA-1 expressed in these cells. Indeed, although excluded from microvilli, LFA-1 on Jurkat cells was still able to tether to ICAM-1 at comparably high shear stresses relative to those permissive for LFA-1-mediated tethering of K562 cells to ICAM-1 (data not shown). Therefore, the ability of LFA-1 expressed in K562 cells to mediate rolling appears to be primarily because of a defect in LFA-1 avidity to ICAM-1 rather than because of markedly higher topographical availability of the integrin for rapid interactions with ICAM-1.
The ability of the LFA-1:ICAM-1 pair to participate in rolling adhesions under physiological conditions is clearly more limited than that of the ␣ 4 integrins. First, tethering of LFA-1 to ICAM-1 in the presence of physiological cation concentrations was not as efficient as the tethering of VLA-4 to VCAM-1 or of ␣ 4 ␤ 7 to mucosal addressin cell adhesion molecule-1 (13, 14) . Second, LFA-1-mediated rolling required higher-density ICAM-1 than was required for ␣ 4 integrin-mediated rolling on VCAM-1 (data not shown). Third, in contrast to LFA-1, the ability of the VLA-4 integrin to support rolling on its endothelial ligand VCAM-1 is not cell-type-restricted, in that this integrin supports rolling of several types of cells, including T cells, polymorphonuclear cells, and hematopoietic progenitors (12-15, 56, 57) . Therefore, we predict that rolling through LFA-1 may take place mainly in a context of another rolling interaction initiated by a selectin or ␣ 4 integrin. Indeed, recent studies implicate the LFA-1:ICAM-1 interaction in rolling adhesions promoted by P-and L-selectin. The stability of leukocyte rolling mediated by these selectins on inflamed vessel walls is significantly reduced in ICAM-1 knockout mice (58) after either trauma or cytokine-induced inflammation. Reduction in physiologic shear rates has been shown in another study to enhance CD11/CD18-dependent, selectin-independent leukocyte rolling in vivo, suggesting that LFA-1 mediates weak rolling interactions on inflamed vessel walls under particular conditions (59). Our results would predict that to engage in rolling interactions with endothelial ICAM-1, LFA-1 must be restricted from forming multivalent receptor:ligand clusters. Such restriction may be regulated by the cytoskeletal associations of the integrin. Small subsets of circulating leukocytes may regulate the cytoskeletal associations of LFA-1 such that they can engage in reversible rolling adhesions on ICAM-1 in vivo. Taken together, the multistep paradigm of leukocyte adhesion to specific endothelial sites may be more complex than previously realized. Rather than a sequential process conducted by distinct adhesive steps, which are exclusively mediated by either selectins or integrins, leukocytes may use weak interactions of both ␣ 4 integrins and LFA-1 with their respective ligands to stabilize selectin-initiated rolling. The LFA-1-mediated rolling demonstrated in the present study further increases the complexity and functional diversity of adhesive cascades, which determine the cell-type-specific recruitment of circulating leukocytes at sites of inflammation and at specialized hematopoietic beds.
